Clinical Trial

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Study acronym: ReMATCH
Recruiting
View on ClinicalTrials.gov →
Summary
The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.
Protocol Amendment History 1 change
notable Trial sites expanded: 34 -> 39 locations 2026-05-06
Trial Details
NCT Number NCT06735534
Lead Sponsor Boston Scientific Corporation
Conditions Persistent Atrial Fibrillation
Enrollment 376 participants
Start Date 2025-06-03
Primary Completion 2027-04 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-27